Fas/CD95 Signaling Pathway in Damage-Associated Molecular Pattern (DAMP)-Sensing Receptors

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2022 May 14

PMID 35563744

Authors

Gael Galli

Pierre Vacher

Bernhard Ryffel

Patrick Blanco

Patrick Legembre

Affiliations

Soon will be listed here.

Abstract

Study of the initial steps of the CD95-mediated signaling pathways is a field of intense research and a long list of actors has been described in the literature. Nonetheless, the dynamism of protein-protein interactions (PPIs) occurring in the presence or absence of its natural ligand, CD95L, and the cellular distribution where these PPIs take place render it difficult to predict what will be the cellular outcome associated with the receptor engagement. Accordingly, CD95 stimulation can trigger apoptosis, necroptosis, pyroptosis, or pro-inflammatory signaling pathways such as nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and phosphatidylinositol-3-kinase (PI3K). Recent data suggest that CD95 can also activate pattern recognition receptors (PRRs) known to sense damage-associated molecular patterns (DAMPs) such as DNA debris and dead cells. This activation might contribute to the pro-inflammatory role of CD95 and favor cancer development or severity of chronic inflammatory and auto-immune disorders. Herein, we discuss some of the molecular links that might connect the CD95 signaling to DAMP sensors.

Citing Articles

Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression.

He R, Liu Y, Fu W, He X, Liu S, Xiao D Mol Cancer. 2024; 23(1):267.

PMID: 39614268 PMC: 11606237. DOI: 10.1186/s12943-024-02172-y.

The Crosstalk of Apoptotic and Non-Apoptotic Signaling in CD95 System.

Seyrek K, Espe J, Reiss E, Lavrik I Cells. 2024; 13(21.

PMID: 39513921 PMC: 11545656. DOI: 10.3390/cells13211814.

The Necroptosis Pathway Is Upregulated in the Cornea in Mice With Ocular Graft-Versus-Host Disease.

Asai K, Lee H, Sato S, Shimizu E, Jung J, Okazaki T Invest Ophthalmol Vis Sci. 2024; 65(10):38.

PMID: 39189995 PMC: 11361379. DOI: 10.1167/iovs.65.10.38.

Targeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies.

Shen J, Wang Q, Mao Y, Gao W, Duan S MedComm (2020). 2023; 4(3):e288.

PMID: 37256211 PMC: 10225743. DOI: 10.1002/mco2.288.

Macrophages in aseptic loosening: Characteristics, functions, and mechanisms.

Cong Y, Wang Y, Yuan T, Zhang Z, Ge J, Meng Q Front Immunol. 2023; 14:1122057.

PMID: 36969165 PMC: 10030580. DOI: 10.3389/fimmu.2023.1122057.

References

Hoogwater F, Nijkamp M, Smakman N, Steller E, Emmink B, Westendorp B . Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells. Gastroenterology. 2010; 138(7):2357-67. DOI: 10.1053/j.gastro.2010.02.046. View

Prakriya M, Feske S, Gwack Y, Srikanth S, Rao A, Hogan P . Orai1 is an essential pore subunit of the CRAC channel. Nature. 2006; 443(7108):230-3. DOI: 10.1038/nature05122. View

Kurma K, Boizard-Moracchini A, Galli G, Jean M, Vacher P, Blanco P . Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?. Biochim Biophys Acta Rev Cancer. 2021; 1876(2):188596. DOI: 10.1016/j.bbcan.2021.188596. View

Cursi S, Rufini A, Stagni V, Condo I, Matafora V, Bachi A . Src kinase phosphorylates Caspase-8 on Tyr380: a novel mechanism of apoptosis suppression. EMBO J. 2006; 25(9):1895-905. PMC: 1456929. DOI: 10.1038/sj.emboj.7601085. View

Wang H, Sun L, Su L, Rizo J, Liu L, Wang L . Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol Cell. 2014; 54(1):133-146. DOI: 10.1016/j.molcel.2014.03.003. View

Li H, Kobayashi M, Blonska M, You Y, Lin X . Ubiquitination of RIP is required for tumor necrosis factor alpha-induced NF-kappaB activation. J Biol Chem. 2006; 281(19):13636-13643. DOI: 10.1074/jbc.M600620200. View

Letellier E, Kumar S, Sancho-Martinez I, Krauth S, Funke-Kaiser A, Laudenklos S . CD95-ligand on peripheral myeloid cells activates Syk kinase to trigger their recruitment to the inflammatory site. Immunity. 2010; 32(2):240-52. DOI: 10.1016/j.immuni.2010.01.011. View

Bell B, Leverrier S, Weist B, Newton R, Arechiga A, Luhrs K . FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A. 2008; 105(43):16677-82. PMC: 2575479. DOI: 10.1073/pnas.0808597105. View

Senft J, Helfer B, Frisch S . Caspase-8 interacts with the p85 subunit of phosphatidylinositol 3-kinase to regulate cell adhesion and motility. Cancer Res. 2007; 67(24):11505-9. DOI: 10.1158/0008-5472.CAN-07-5755. View

10.

Grootjans S, Vanden Berghe T, Vandenabeele P . Initiation and execution mechanisms of necroptosis: an overview. Cell Death Differ. 2017; 24(7):1184-1195. PMC: 5520172. DOI: 10.1038/cdd.2017.65. View

11.

Qadir A, Guegan J, Ginestier C, Chaibi A, Bessede A, Charafe-Jauffret E . CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells. iScience. 2021; 24(11):103348. PMC: 8593563. DOI: 10.1016/j.isci.2021.103348. View

12.

Kischkel F, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer P . Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995; 14(22):5579-88. PMC: 394672. DOI: 10.1002/j.1460-2075.1995.tb00245.x. View

13.

Teodorczyk M, Kleber S, Wollny D, Sefrin J, Aykut B, Mateos A . CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma. Cell Death Differ. 2015; 22(7):1192-202. PMC: 4572867. DOI: 10.1038/cdd.2014.217. View

14.

Canna S, de Jesus A, Gouni S, Brooks S, Marrero B, Liu Y . An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet. 2014; 46(10):1140-6. PMC: 4177369. DOI: 10.1038/ng.3089. View

15.

Yamamoto S, Shimizu S, Kiyonaka S, Takahashi N, Wajima T, Hara Y . TRPM2-mediated Ca2+influx induces chemokine production in monocytes that aggravates inflammatory neutrophil infiltration. Nat Med. 2008; 14(7):738-47. PMC: 2789807. DOI: 10.1038/nm1758. View

16.

Vanden Berghe T, Linkermann A, Jouan-Lanhouet S, Walczak H, Vandenabeele P . Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol. 2014; 15(2):135-47. DOI: 10.1038/nrm3737. View

17.

Zhong H, May M, Jimi E, Ghosh S . The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell. 2002; 9(3):625-36. DOI: 10.1016/s1097-2765(02)00477-x. View

18.

Seino K, Kayagaki N, Okumura K, Yagita H . Antitumor effect of locally produced CD95 ligand. Nat Med. 1997; 3(2):165-70. DOI: 10.1038/nm0297-165. View

19.

Lee S, Karki R, Wang Y, Nguyen L, Kalathur R, Kanneganti T . AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature. 2021; 597(7876):415-419. PMC: 8603942. DOI: 10.1038/s41586-021-03875-8. View

20.

Fields M, Sokol C, Eaton-Bassiri A, Seo S, Madaio M, Erikson J . Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J Immunol. 2001; 167(4):2370-8. DOI: 10.4049/jimmunol.167.4.2370. View